sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks 5-Phenyl-1,3,4-oxadiazol-2-amine

5-Phenyl-1,3,4-oxadiazol-2-amine

CAS No.:
1612-76-6
Catalog Number:
AG001S98
Molecular Formula:
C8H7N3O
Molecular Weight:
161.1607
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
95%
In Stock USA
United States
$40
- +
5g
95%
In Stock USA
United States
$114
- +
10g
95%
In Stock USA
United States
$169
- +
Product Description
Catalog Number:
AG001S98
Chemical Name:
5-Phenyl-1,3,4-oxadiazol-2-amine
CAS Number:
1612-76-6
Molecular Formula:
C8H7N3O
Molecular Weight:
161.1607
MDL Number:
MFCD00126383
IUPAC Name:
5-phenyl-1,3,4-oxadiazol-2-amine
InChI:
InChI=1S/C8H7N3O/c9-8-11-10-7(12-8)6-4-2-1-3-5-6/h1-5H,(H2,9,11)
InChI Key:
CQSFYCBGVMWPCM-UHFFFAOYSA-N
SMILES:
Nc1nnc(o1)c1ccccc1
NSC Number:
116132
Properties
Complexity:
147  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
161.059g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
161.164g/mol
Monoisotopic Mass:
161.059g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
64.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.7  
Literature
Title Journal
5-Phenyl-1,3,4-oxadiazol-2-amine. Acta crystallographica. Section E, Structure reports online 20121001
Tetra-kis[μ(3)-4-nitro-N-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamidato]tetra-kis-[methano-lsodium(I)]. Acta crystallographica. Section E, Structure reports online 20120501
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Properties